Welcure Drugs And Pharmaceuticals (WDPL) is engaged in the manufacture of bulk drugs and pharmaceutical formulations, including antibiotics and vitamins, offering over a hundred varieties of products.

The company has a strategic collaboration agreement with a Russian firm to be the sole selling agent for Stevioside, a sugar substitute, enhancing its portfolio and market reach.

Welcure has diversified its product line by adding sections for paediatric and veterinary drugs, as well as expanding into ointments and liquid syrups.

It boasts a strong infrastructure with a new liquid oral plant and ISO 9002 certification, ensuring high quality and standards for its products.